EFPIA states AI rules must “enable not hinder” pharma R&D
Drug Discovery World
APRIL 24, 2024
Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance. This would ensure that rules enable, rather than hinder, the development of safe and effective treatments that reach patients faster and more efficiently.”
52 
Let's personalize your content